Washington University in St. Louis (WU)
Dr. Braverman is interested in genetically triggered thoracic aortic diseases and is Director of the Marfan Syndrome Clinic. His clinical research interests include Marfan syndrome, Loeys-Dietz aneurysm syndrome, Bicuspid aortic valve aortopathy, familial thoracic aortic aneurysm/dissection syndromes and vascular Ehlers-Danlos syndromes. Dr. Braverman is an investigator involved in the International Registry of Aortic Dissection (IRAD) and participates in the NHLBI trial of Atenolol vs. Losartan in Marfan Syndrome.